Welcome to the new Gustave Roussy website

A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.

Home

Department of Medical Biology and Pathology - Publications

Clinicians, biologists, and pathologists actively contribute to the research conducted at Gustave Roussy within their respective fields of specialization. Some of them head research units or platforms.

Many of them are active in professional societies in their respective fields and help organize national and international conferences.

Number of publications in 2023 by type

Number of publications in 2023 by category and position

1 = 7; 2 = 14; 3 = 10; Inv (Investigator) = 4; k (Any intermediate position between 3 and ADA) = 76; ADA (Second-to-Last Author) = 8; DA (Last Author) = 5.

Breakdown by category

Publications by discipline

DM: ONCOLOGY; TM: PATHOLOGY; YA: SURGERY; SD: OBSTETRICS & GYNECOLOGY; RO: MULTIDISCIPLINARY SCIENCES; MA: HEMATOLOGY; KM: GENETICS & HEREDITY; IA: ENDOCRINOLOGY & METABOLISM; KI: GASTROENTEROLOGY & HEPATOLOGY; DR: CELL BIOLOGY.

Major Publications

  • Aldea, M., D. Vasseur, A. Italiano, and S.I. Nikolaev. “WGS/WES-RNAseq Compared to Targeted NGS in Oncology: Is There Something to Unlock?” ” *Annals of Oncology* 34, no. 12 (December 2023): 1090–93. https://doi.org/10.1016/j.annonc.2023.09.3118.
  • Labidi-Galy, S.I., M. Rodrigues, J.L. Sandoval, J.E. Kurtz, F. Heitz, A.M. Mosconi, I. Romero, et al. “Association of Location of BRCA1 and BRCA2 Mutations with Benefit from Olaparib and Bevacizumab Maintenance in High-Grade Ovarian Cancer: Phase III PAOLA-1/ENGOT-Ov25 Trial Subgroup Exploratory Analysis.” Annals of Oncology 34, no. 2 (February 2023): 152–62. https://doi.org/10.1016/j.annonc.2022.11.003.
  • Roussel-Simonin, Cyril, Felix Blanc-Durand, Roseline Tang, Damien Vasseur, Audrey Le Formal, Laure Chardin, Elisa Yaniz, et al. “Homologous Recombination Deficiency (HRD) Testing on Cell-Free Tumor DNA from Peritoneal Fluid.” Molecular Cancer 22, no. 1 (November 6, 2023): 178. https://doi.org/10.1186/s12943-023-01864-1.
  • Blanc-Durand, Félix, Roseline Tang, Margaux Pommier, Marzieh Nashvi, Sophie Cotteret, Catherine Genestie, Audrey Le Formal, et al. “Clinical Relevance of BRCA1 Promoter Methylation Testing in Patients with Ovarian Cancer.” Clinical Cancer Research 29, no. 16 (August 15, 2023): 3124–29. https://doi.org/10.1158/1078-0432.CCR-22-3328.
  • Kfoury, Maria, Reda El Hazzaz, Claire Sanson, Felix Blanc Durand, Judith Michels, Emeline Colomba Blameble, Roseline Tang, et al. “Circulating Tumor DNA from Ascites as an Alternative to Tumor Sampling for Genomic Profiling in Ovarian Cancer Patients .” *Biomarker Research* 11, no. 1 (October 20, 2023): 93. https://doi.org/10.1186/s40364-023-00533-1.
  • Moya-Plana, Antoine, Carine Ngo, Emilie Lanoy, Stephan Vagner, and Caroline Robert. “eIF4F Translation Initiation Complex, a Predictive Marker of Response to Immunotherapy in Mucosal Melanoma.” European Journal of Cancer 184 (May 2023): 120–23. https://doi.org/10.1016/j.ejca.2023.01.032.
  • Midey, Charlotte, Silvana Kalakech, Ludovic Lacroix, Jean-Claude Dib, Stephane Aubert, Julien Rosencher, Arthur Cescau, et al. “A Case of Intracardiac RREB1::MKL2 Spindle-Cell Mesenchymal Tumor.” Canadian Journal of Cardiology 39, no. 7 (July 2023): 1011–13. https://doi.org/10.1016/j.cjca.2023.03.018.
  • Borcoman, Edith, Elizabeth Santana Dos Santos, Catherine Genestie, Patricia Pautier, Ludovic Lacroix, Sandrine M. Caputo, Odile Cabaret, et al. “Combined Tumor-Based BRCA1/2 and TP53 Mutation Testing in Ovarian Cancer.” International Journal of Molecular Sciences 24, no. 14 (July 18, 2023): 11570. https://doi.org/10.3390/ijms241411570.
  • Valery, Marine, Damien Vasseur, Francesco Fachinetti, Alice Boilève, Cristina Smolenschi, Anthony Tarabay, Leony Antoun, et al. “Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments.” Cancers 15, no. 18 (September 6, 2023): 4446. https://doi.org/10.3390/cancers15184446.
  • López, Fernando, Abir Al Ghuzlan, Mark Zafereo, Vincent Vander Poorten, K. Thomas Robbins, Marc Hamoir, Iain J. Nixon, et al. “Neck Surgery for Non-Well-Differentiated Thyroid Malignancies: Variations in Strategy According to Histopathology.” Cancers 15, no. 4 (February 16, 2023): 1255. https://doi.org/10.3390/cancers15041255.
  • Suciu, Voichita, Carolla El Chamieh, Ranya Soufan, Marie-Christine Mathieu, Corinne Balleyguier, Suzette Delaloge, Zsofia Balogh, Jean-Yves Scoazec, Sylvie Chevret, and Philippe Vielh. “Real-World Diagnostic Accuracy of the On-Site Cytopathology Advance Report (OSCAR) Procedure Performed in a Multidisciplinary One-Stop Breast Clinic.” Cancers 15, no. 20 (October 13, 2023): 4967. https://doi.org/10.3390/cancers15204967
  • Perrier, Marine, Jean-Yves Scoazec, and Thomas Walter. “A Practical Proposal on Treatment Sequencing of Metastatic Well-Differentiated Neuroendocrine Tumors.” Therapeutic Advances in Medical Oncology 15 (January 2023): 175883592311710. https://doi.org/10.1177/17588359231171041.
  • Blanc-Durand, Félix, Elisa Yaniz-Galende, Alba Llop-Guevara, Catherine Genestie, Violeta Serra, Andrea Herencia-Ropero, Christophe Klein, et al. “Corrigendum to ‘A RAD51 Functional Assay as a Candidate Test for Homologous Recombination Deficiency in Ovarian Cancer.’” Gynecologic Oncology 175 (August 2023): 194. https://doi.org/10.1016/j.ygyno.2023.05.058
  • Blanc-Durand, Félix, Elisa Yaniz-Galende, Alba Llop-Guevara, Catherine Genestie, Violeta Serra, Andrea Herencia-Ropero, Christophe Klein, et al. “A RAD51 Functional Assay as a Candidate Test for Homologous Recombination Deficiency in Ovarian Cancer.” Gynecologic Oncology 171 (April 2023): 106–13. https://doi.org/10.1016/j.ygyno.2023.01.026
  • Hadoux, Julien, Abir Al Ghuzlan, Livia Lamartina, Mohamed-Amine Bani, Sophie Moog, Marie Attard, Jean Yves Scoazec, et al. “Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.” JCO Precision Oncology, no. 7 (September 2023): e2300053. https://doi.org/10.1200/PO.23.00053
  • Mamodaly, Maria, Ruiqian Chen, Lydia Deschamps, Louis De Mestier, Anne Couvelard, Jean Yves Scoazec, and Jérôme Cros. “When It Comes to Chromogranin A, Not All Clones Are Made Equal.” Pathology 55, no. 1 (February 2023): 149–53. https://doi.org/10.1016/j.pathol.2022.04.004.
  • Assi, Tarek, Carine Ngo, Matthieu Faron, Benjamin Verret, Antonin Lévy, Charles Honoré, Clémence Hénon, Cécile Le Péchoux, Rastilav Bahleda, and Axel Le Cesne. “Systemic Therapy in Advanced Pleomorphic Liposarcoma: A Comprehensive Review.” Current Treatment Options in Oncology, October 16, 2023. https://doi.org/10.1007/s11864-023-01139-3
  • Combarel, David, Julie Tran, Julia Delahousse, Gilles Vassal, and Angelo Paci. “Individualizing Busulfan Dose in Specific Populations and Evaluating the Risk of Pharmacokinetic Drug-Drug Interactions.” Expert Opinion on Drug Metabolism & Toxicology 19, no. 2 (February 1, 2023): 75–90. https://doi.org/10.1080/17425255.2023.2192924.
  • Nadal, N., N. Auger, A. Bidet, and F. Nguyen-Khac. “Cytogenetics in the Management of Clonal Chromosomal Abnormalities of Undetermined Significance and Persistent Polyclonal B-Cell Lymphocytosis: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).” Current Research in Translational Medicine 71, no. 4 (October 2023): 103426. https://doi.org/10.1016/j.retram.2023.103426.
  • Auger, Nathalie, Nathalie Douet-Guilbert, Julie Quessada, Olivier Theisen, Marina Lafage-Pochitaloff, and Marie-Bérengère Troadec. “Cytogenetics in the Management of Myelodysplastic Neoplasms (Myelodysplastic Syndromes, MDS): Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).” *Current Research in Translational Medicine* 71, no. 4 (October 2023): 103409. https://doi.org/10.1016/j.retram.2023.103409.
  • Hartl, Dana M., Abir Al Ghuzlan, Sophie Bidault, Ingrid Breuskin, Joanne Guerlain, Elizabeth Girard, Eric Baudin, Livia Lamartina, and Julien Hadoux. “Risk Staging with Prophylactic Unilateral Central Neck Dissection in Low-Risk Papillary Thyroid Carcinoma.” European Journal of Surgical Oncology 49, no. 3 (March 2023): 568–74. https://doi.org/10.1016/j.ejso.2022.11.007
  • Ngo, Carine, Benjamin Verret, Julien Vibert, Sophie Cotteret, Antonin Levy, Cécile Le Pechoux, Leila Haddag‐Miliani, et al. “A Novel Fusion Variant LSM14A::NR4A3 in Extraskeletal Myxoid Chondrosarcoma.” Genes, Chromosomes and Cancer 62, no. 1 (January 2023): 52–56. https://doi.org/10.1002/gcc.23090
  • Gessain, Grégoire, Natacha Joyon, Thomas Petit, Sophie Cotteret, and Magali Lacroix-Triki. “Uncommon Invasive Lobular Carcinoma with Papillary Architecture—Clinicopathologic and Molecular Characterization with Review of the Literature.” *Virchows Archiv* 483, no. 5 (November 2023): 723–29. https://doi.org/10.1007/s00428-023-03526-5.
  • Rinke, Anja, Valentina Ambrosini, Clarisse Dromain, Rocio Garcia‐Carbonero, Amyn Haji, Anna Koumarianou, Els Nieveen Van Dijkum, et al. “European Neuroendocrine Tumor Society (ENETS) 2023 Guidance Paper for Colorectal Neuroendocrine Tumors.” Journal of Neuroendocrinology 35, no. 6 (June 2023): e13309. https://doi.org/10.1111/jne.13309
  • Khneisser, Pierre, Mohamed-Amine Bani, Sophie Cotteret, Nizar Labaied, Charles Honore, Gregory Guimard, Pablo Berlanga, and Jean-Yves Scoazec. “Malignant Gastrointestinal Neuroectodermal Tumor as a Second Malignancy Following Ewing Sarcoma: Diagnostic Pitfalls in the EWSR1-rearranged Tumor Spectrum.” *Pediatric Blood & Cancer* 70, no. 9 (September 2023): e30438. https://doi.org/10.1002/pbc.30438.
  • Conversano, Angelica, Muriel Abbaci, Paul Van Diest, Aurélie Roulot, Giuseppe Falco, Malek Ferchiou, Saverio Coiro, et al. “Breast Carcinoma Detection in Ex Vivo Fresh Human Breast Surgical Specimens Using a Fast Slide-Free Confocal Microscopy Scanner: HIBISCUSS Project.” BJS Open 7, no. 3 (May 5, 2023): zrad046. https://doi.org/10.1093/bjsopen/zrad046
  • Baz, M., V. Gondran-Teiller, B. Bressac, O. Cabaret, A. Fievet, M. Dimaria, V. Goldbarg, et al. “The Frequency of Germline BRCA and Non-BRCA HR-Gene Variants in a Cohort of Pancreatic Cancer Patients.” Digestive Diseases and Sciences 68, no. 4 (April 2023): 1525–28. https://doi.org/10.1007/s10620-022-07733-z.
  • Saleh, Khalil, Ahmadreza Arbab, David Ghez, Camille Bigenwald, Sophie Cotteret, Christophe Marzac, Florence Pasquier, et al. “Myelodysplastic Syndrome Following Chimeric Antigen Receptor T-Cell Therapy Treated with Allogeneic Stem Cell Transplantation.” *Immunotherapy* 15, no. 6 (April 2023): 401–7. https://doi.org/10.2217/imt-2022-0205.
  • Ghigna, Mr, S Cotteret, A Arbab, Ma Bani, and Jy Scoazec. “Small Cell Lung Cancer with SYN2::PPARG Fusion.” Pathology - Research and Practice 251 (November 2023): 154904. https://doi.org/10.1016/j.prp.2023.154904.
  • Selle, Frédéric, Florence Joly, Laurence Gladieff, Karine Prulhière, Alexandra Leary, Elsa Kalbacher, Etienne Rouleau, and Isabelle Ray-Coquard. “Management of Advanced-Stage (III–IV) High-Grade Serous and/or Endometrioid Ovarian Carcinomas and HRD-BRCA Testing in 2023: An Update Based on Data Published and/or Presented in 2022.” Bulletin du Cancer 110, no. 6 (June 2023): 6S5–9. https://doi.org/10.1016/S0007-4551(23)00329-6.
  • Pautier, Patricia, Catherine Genestie, Laurence Gladieff, Jean-Emmanuel Kurtz, Alain Lortholary, Thibault De La Motte Rouge, Anne-Lise Gaillard, et al. “Nice/Saint-Paul-de-Vence 2022–2023 Clinical Practice Recommendations: Management of Advanced Cervical Cancer.” Bulletin du Cancer 110, no. 6 (June 2023): 6S44–50. https://doi.org/10.1016/S0007-4551(23)00333-8.
  • Karabajakian, Andy, Catherine Genestie, Pierre Meeus, Frédéric Guyon, Carmen Llacer Moscardo, Sabrina Croce, Sophie Taieb, et al. “Müllerian Adenosarcomas of the Uterus—Management Guidelines from the GSF-GETO/NETSARC+ and TMRG Groups.” Bulletin du Cancer 110, no. 7–8 (July 2023): 836–43. https://doi.org/10.1016/j.bulcan.2023.04.017.
  • Collineau, Bérénice, Catherine Genestie, Sabrina Croce, Pierre Meeus, Anne Floquet, Frédéric Guyon, Carmen Llacer-Moscardo, et al. “Uterine Leiomyosarcomas—Management Guidelines from the GSF-GETO/NETSARC+ and TMRG Groups.” Bulletin du Cancer 110, no. 4 (April 2023): 440–49. https://doi.org/10.1016/j.bulcan.2023.01.009
  • Jeanne, Corinne, Isabelle Treilleux, Marie-Aude Le Frère-Belda, Jérôme Alexandre, Florence Joly, and Etienne Rouleau. “Nice/Saint-Paul-de-Vence 2022–2023 Clinical Practice Recommendations: Histomolecular Diagnosis of Endometrial Carcinomas.” Bulletin du Cancer 110, no. 6 (June 2023): 6S10–19. https://doi.org/10.1016/S0007-4551(23)00330-2.
  • Joyon, Natacha, Zoe Guillaume, Lamia Ouafi, Sophie Cotteret, Etienne Rouleau, Olivier Caron, Veronica Goldbarg, and Magali Lacroix-Triki. “Malignant Adenomyoepithelioma of the Breast: An Unexpected Malignancy in a Lynch Syndrome Patient.” International Journal of Surgical Pathology 31, no. 5 (August 2023): 572–75. https://doi.org/10.1177/10668969221105623
  • Joyon, Natacha, Marie-Christine Mathieu, Etienne Rouleau, Aurélie Roulot-Paumelle, Jean-Yves Scoazec, and Voichita Suciu. “Diagnostic Challenges and Pitfalls of Mammary Pleomorphic Adenoma Illustrated by a Case Report.” *International Journal of Surgical Pathology* 31, no. 4 (June 2023): 472–77. https://doi.org/10.1177/10668969221102552.